Manal Morsy, Senior VP & Head of Global Regulatory Affairs at Athersys, will be participating in the International Society for Cell & Gene Therapy Annual Meeting on Wednesday, May 4th in San Francisco, California. She'll join industry experts in two roundtable discussions titled "Global Market Strategies & Entering APAC Market" and "Innovative Cell and Gene Therapy Clinical Trial Design and Development Strategies to Enhance Inclusivity and Diversity".
Additionally, Rochelle Cutrone, Associate Scientist at Athersys, will be presenting a poster at ISCT titled "Multipotent adult progenitor cells modulate monocyte/macrophage phenotype, cytokine secretion and function".
More information is available on the conference here: https://www.isctglobal.org/isct2022/